English
Home > Products > Citalopram API

China Citalopram API Factory

We purpose to understand high quality disfigurement with the output and supply the top service to domestic and overseas buyers wholeheartedly for Citalopram API,CAS NO:59729-32-7,Citalopram hydrobromide API,Citalopram hydrobromide,Citalopram, We've been willing to provide you with the lowest selling price during the market place, greatest high quality and quite nice sales service.Welcome to do bussines with us,let's be double win.
Citalopram API, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Related Products

Hot Products

  • Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate

    Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate

    Product Name:Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate
    Molecular Formula:C26H23N3O3
    Molecular Weight:425.48
    CAS Registry Number:139481-41-7
  • Methotrexate disodium salt

    Methotrexate disodium salt

    Product Name:Methotrexate disodium salt
    Molecular Formula:C20H23N8NaO5
    Molecular Weight:478.44
    CAS Registry Number;7413-34-5
  • Semicarbazide hydrochloride

    Semicarbazide hydrochloride

    Product Name:Semicarbazide hydrochloride
    Molecular Formula:CH6ClN3O
    Molecular Weight;111.53
    CAS Registry Number;563-41-7
  • 3,5,6-Trichlorosalicylic acid

    3,5,6-Trichlorosalicylic acid

    Product Name:3,5,6-Trichlorosalicylic acid
    Molecular Formula:C7H3Cl3O3
    Molecular Weight:241.46
    CAS Registry Number:40932-60-3
  • Baloxavir

    Baloxavir

    Product Name:Baloxavir
    Molecular Formula:C24H19F2N3O4S
    Molecular Weight;483.49
    CAS Registry Number;1985605-59-1
  • Praziquantel

    Praziquantel

    Product Name:Praziquantel
    Molecular Formula:C19H24N2O2
    Molecular Weight;312.41
    CAS Registry Number;55268-74-1
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

Escitalopram API

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept